Physician profile
William L Hickerson
NPI 1033209606
$833,353.28
in general payments reported to CMS, 2019-2025
25 companies · $1,001 in 2025
The $1,001 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $6,303 · 2021: $45K · 2022: $672K · 2023: $57K · 2024: $30K · 2025: $1,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $80K · Honoraria: $6,000 · Food and Beverage: $1,411 · Travel and Lodging: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $79,575.00 |
| Honoraria | $6,000.00 |
| Food and Beverage | $1,410.67 |
| Travel and Lodging | $1,120.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Triad Life Sciences INC. | $669,183.82 | 2021-2022 | |
| Avita Medical Americas, LLC | $114,436.27 | 2019-2023 | Recell |
| Polynovo North America LLC | $30,457.41 | 2019-2025 | Novosorb Btm |
| Urgo Medical North America, LLC | $5,000.00 | 2019 | |
| Vericel Corporation | $4,600.51 | 2019-2024 | Nexobrid, Epicel (Cultured Epidermal Autografts) |
| Lumenis, INC | $2,654.10 | 2019-2021 | |
| Lumenis Be INC | $2,500.00 | 2022 | |
| Medline Industries Lp | $2,317.29 | 2019-2022 | |
| Access Pro Medical, LLC | $876.57 | 2025 | Matriderm |
| Ethicon US, LLC | $394.95 | 2019-2020 | |
| Sientra, INC. | $175.29 | 2019-2020 | |
| Smith+Nephew, INC. | $126.64 | 2019-2021 | |
| Ovik Health, LLC | $119.68 | 2019-2020 | |
| Medela LLC | $100.92 | 2021 | |
| Misonix INC | $86.35 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $83.94 | 2025 | Truelok |
| Organogenesis INC. | $59.20 | 2019 | |
| Kerecis Limited | $35.65 | 2019-2021 | |
| Melinta Therapeutics, LLC | $34.33 | 2019 | |
| Kci USA, INC. | $28.47 | 2019-2020 | |
| Acelrx Pharmaceuticals, INC. | $24.77 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $24.50 | 2019 | |
| Allergan, INC. | $17.26 | 2019 | |
| Polarityte, INC. | $15.36 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hickerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.